FINANCIALS

KRYS Krystal Biotech Inc 1711279

Income Statement
Revenue	krys-20241231	290,515,000
Net Income	krys-20241231	89,159,000
Profit Margin		30.69%

Balance Sheet
Current Assets	742,045,000
Assets	1,055,838,000
Current Liabilities	101,995,000
Liabilities	109,458,000
Equity	946,380,000
Shares Out	28,730,000

Cash Flow Statement
Operating Cash Flow	123,420,000
Investing Cash Flow	-163,439,000

Market Analysis
Market Cap	5,401,228,720
Price	188.23
BVPS	32.94
PB	5.73
EPS	3.65
PE	51.54
PS	4.65
FCF	-40,019,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view KRYS documents filed with the SEC.

KRYS Filings Clear

View A List of Tickers